Cargando…

An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases

INTRODUCTION: Common protocols for the detection of sentinel lymph nodes in early breast cancer often include the injection of the tracer 1 day before surgery. In order to detect enough activity on the day of surgery, the applied activity in many protocols is as high as several hundred MBq. So far,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolberg, Hans-Christian, Afsah, Shabnam, Kuehn, Thorsten, Winzer, Ute, Akpolat-Basci, Leyla, Stephanou, Miltiades, Wetzig, Sarah, Hoffmann, Oliver, Liedtke, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762074/
https://www.ncbi.nlm.nih.gov/pubmed/28875761
http://dx.doi.org/10.1177/1533034617728862
_version_ 1783291629620166656
author Kolberg, Hans-Christian
Afsah, Shabnam
Kuehn, Thorsten
Winzer, Ute
Akpolat-Basci, Leyla
Stephanou, Miltiades
Wetzig, Sarah
Hoffmann, Oliver
Liedtke, Cornelia
author_facet Kolberg, Hans-Christian
Afsah, Shabnam
Kuehn, Thorsten
Winzer, Ute
Akpolat-Basci, Leyla
Stephanou, Miltiades
Wetzig, Sarah
Hoffmann, Oliver
Liedtke, Cornelia
author_sort Kolberg, Hans-Christian
collection PubMed
description INTRODUCTION: Common protocols for the detection of sentinel lymph nodes in early breast cancer often include the injection of the tracer 1 day before surgery. In order to detect enough activity on the day of surgery, the applied activity in many protocols is as high as several hundred MBq. So far, very few protocols with an activity below 20 MBq have been reported. We developed an ultralow-dose 1-day protocol with a mean activity lower than 20 MBq in order to reduce radiation exposure for patients and staff. Here, we are presenting our experiences in 150 consecutive cases. MATERIALS AND METHODS: A total of 150 patients with clinically and sonographically negative axilla and no multicentricity underwent a sentinel lymph node biopsy using an ultralow-dose protocol performed on the day of surgery. No patient received systemic therapy prior to sentinel node biopsy. After peritumoral injection of the tracer Technetium-99m, a lymphoscintigraphy was performed in all cases. Seven minutes before the first cut, we injected 5 mL of blue dye in the region of the areola. RESULTS: In 148 (98.7%) of 150 patients, at least 1 sentinel lymph node could be identified by lymphoscintigraphy; the detection rate during surgery with combined tracers Technetium-99m and blue dye was 100%. The mean applied activity was 17.8 MBq (9-20). A mean number of 1.3 (0-5) sentinel lymph nodes were identified by lymphoscintigraphy and a mean number of 1.8 (1-5) sentinel lymph nodes were removed during sentinel lymph node biopsy. CONCLUSION: Ultralow-dose 1-day protocols with an activity lower than 20 MBq are a safe alternative to 1-day or 2-day protocols with significantly higher radiation doses in primary surgery for early breast cancer. Using Technetium-99m and blue dye in a dual tracer approach, detection rates of 100% are possible in clinical routine in order to reduce radiation exposure for patients and staff.
format Online
Article
Text
id pubmed-5762074
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-57620742018-01-17 An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases Kolberg, Hans-Christian Afsah, Shabnam Kuehn, Thorsten Winzer, Ute Akpolat-Basci, Leyla Stephanou, Miltiades Wetzig, Sarah Hoffmann, Oliver Liedtke, Cornelia Technol Cancer Res Treat Original Articles INTRODUCTION: Common protocols for the detection of sentinel lymph nodes in early breast cancer often include the injection of the tracer 1 day before surgery. In order to detect enough activity on the day of surgery, the applied activity in many protocols is as high as several hundred MBq. So far, very few protocols with an activity below 20 MBq have been reported. We developed an ultralow-dose 1-day protocol with a mean activity lower than 20 MBq in order to reduce radiation exposure for patients and staff. Here, we are presenting our experiences in 150 consecutive cases. MATERIALS AND METHODS: A total of 150 patients with clinically and sonographically negative axilla and no multicentricity underwent a sentinel lymph node biopsy using an ultralow-dose protocol performed on the day of surgery. No patient received systemic therapy prior to sentinel node biopsy. After peritumoral injection of the tracer Technetium-99m, a lymphoscintigraphy was performed in all cases. Seven minutes before the first cut, we injected 5 mL of blue dye in the region of the areola. RESULTS: In 148 (98.7%) of 150 patients, at least 1 sentinel lymph node could be identified by lymphoscintigraphy; the detection rate during surgery with combined tracers Technetium-99m and blue dye was 100%. The mean applied activity was 17.8 MBq (9-20). A mean number of 1.3 (0-5) sentinel lymph nodes were identified by lymphoscintigraphy and a mean number of 1.8 (1-5) sentinel lymph nodes were removed during sentinel lymph node biopsy. CONCLUSION: Ultralow-dose 1-day protocols with an activity lower than 20 MBq are a safe alternative to 1-day or 2-day protocols with significantly higher radiation doses in primary surgery for early breast cancer. Using Technetium-99m and blue dye in a dual tracer approach, detection rates of 100% are possible in clinical routine in order to reduce radiation exposure for patients and staff. SAGE Publications 2017-09-06 2017-12 /pmc/articles/PMC5762074/ /pubmed/28875761 http://dx.doi.org/10.1177/1533034617728862 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Kolberg, Hans-Christian
Afsah, Shabnam
Kuehn, Thorsten
Winzer, Ute
Akpolat-Basci, Leyla
Stephanou, Miltiades
Wetzig, Sarah
Hoffmann, Oliver
Liedtke, Cornelia
An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
title An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
title_full An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
title_fullStr An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
title_full_unstemmed An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
title_short An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
title_sort ultralow-dose 1-day protocol with activities lower than 20 mbq for the detection of sentinel lymph nodes in breast cancer—experiences after 150 cases
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762074/
https://www.ncbi.nlm.nih.gov/pubmed/28875761
http://dx.doi.org/10.1177/1533034617728862
work_keys_str_mv AT kolberghanschristian anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT afsahshabnam anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT kuehnthorsten anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT winzerute anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT akpolatbascileyla anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT stephanoumiltiades anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT wetzigsarah anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT hoffmannoliver anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT liedtkecornelia anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT kolberghanschristian ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT afsahshabnam ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT kuehnthorsten ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT winzerute ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT akpolatbascileyla ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT stephanoumiltiades ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT wetzigsarah ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT hoffmannoliver ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases
AT liedtkecornelia ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases